Science and technology

Russian researchers develop a new pain-relieving compound inspired by sea anemone venom

15 October 20265 min read

Russian researchers develop a new pain-relieving compound inspired by sea anemone venom
A Russian research team develops a new non-addictive painkiller, with clinical trials planned for 2027.

Researchers from the Far Eastern Federal University in Russia announced the development of a new peptide-based drug compound named "HCRG21," which may help alleviate pain by targeting a specific neural mechanism for signal transmission. This development is part of the effort to create alternative painkillers that do not rely on opioids, which are associated with known addiction risks.

The university stated on its website on Wednesday that the compound is based on a molecule discovered in sea anemone venom and works by inhibiting the "TRPV1" channel found in sensory nerve cells. This channel plays a fundamental role in sensing painful stimuli, including high heat and certain irritating chemicals.

Researchers explained that the compound belongs to the class of non-opioid painkillers and targets a mechanism different from those used by opioids acting on opioid receptors in the nervous system. Preliminary results indicate its potential for pain relief, but evaluating its efficacy and safety in humans requires clinical trials.

The research team noted that the active ingredient is produced using a genetically modified microbial strain, rather than being extracted directly from marine organisms. This method facilitates larger-scale production under more controlled conditions. The development of the compound involves the Institute of Bioorganic Chemistry of the Pacific Ocean, part of the Russian Academy of Sciences, along with other Russian research institutions and pharmaceutical companies.

The university reported the completion of preclinical studies, with clinical trials planned to begin in 2027. Final drug registration is targeted for 2030 and 2031, according to a timeline that remains contingent on the results of upcoming tests, which will determine efficacy, safety, appropriate dosages, and potential side effects before it is made available for medical use.

Sea anemones are marine organisms living on the sea floor. They resemble flowers in appearance but are actually small predatory animals belonging to the Cnidaria group, which also includes jellyfish and coral.

Source: Syrian Arab News Agency (SANA)

Comments (0)

0 / 600
No comments yet. Be the first to comment.